Q4 2021 Holdings
Filed 2022-02-15 | 10 holdings | $25.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $24.7M | 103,053 | 98.9% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $44.3K | 204,812 | 0.2% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $43.6K | 69,080 | 0.2% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $42.2K | 564,102 | 0.2% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $38.9K | 156,424 | 0.2% |
| Alkermes PLC(ALKS) | COM | G01767105 | $33.6K | 1,442,965 | 0.1% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $28.5K | 1,557,119 | 0.1% |
| Taro Pharmaceutical Indus | COM | M8737E108 | $27.0K | 538,967 | 0.1% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $5.4K | 106,487 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $186 | 31,027 | 0.0% |